Allergies News and Research

Latest Allergies News and Research

A daily pill to treat covid could be just months away, scientists say

Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble breathing, symptoms serious enough to send her to the emergency room.

24 Sep 2021

COVID-19 transmission is higher with warm weather and increased visits to indoors public places, study finds

A new study finds that environmental factors and human mobility predict seasonal changes in COVID-19 rates, just as in influenza and similar diseases.

23 Sep 2021

Researchers provide structural insights into HCV receptor binding and entry

In a new paper published in Nature, scientists from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, describe the structure of a key protein on the surface of the hepatitis C virus (HCV) and how it interacts with its receptor found on some human cells.

21 Sep 2021

Medical staff with a history of allergy suffered adverse reactions to BNT162b2 COVID-19 vaccine

Scientists have addressed the gap in the research regarding the adverse reactions to the COVID-19 vaccine among individuals with allergies.

20 Sep 2021

COVID-19 vaccine-related allergies are rare, typically mild and treatable, finds study

Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to research from the Stanford University School of Medicine.

20 Sep 2021

Study uncovers five new genetic loci predisposing to atopic dermatitis

An international study led by the University of Oulu's researchers reports five new genetic loci predisposing to atopic dermatitis.

18 Sep 2021

UW Medicine enrolls volunteers for COVID-19 booster vaccine trial

Researchers at the University of Washington School of Medicine are enrolling volunteers for a COVID-19 booster vaccine trial.

18 Sep 2021

Discovery of biological response platform could provide opportunity to alleviate allergic inflammation

New discoveries about a built-in rapid reaction system that triggers inflammatory responses when people are exposed to allergens, such as insects, mites, and fungi, also may hold the keys to helping more people manage their allergies in years to come.

17 Sep 2021

How Fauci and the NIH got ahead of the FDA and CDC in backing boosters

In January — long before the first jabs of covid-19 vaccine were even available to most Americans — scientists working under Dr. Anthony Fauci at the National Institute of Allergy and Infectious Diseases were already thinking about potential booster shots.

16 Sep 2021

Phase I trial investigates using antiparasitic nitazoxanide for treatment of COVID-19

In a recent study, researchers investigate the possibility of using the thiazolide antiparasitic nitazoxanide for the treatment of COVID-19.

15 Sep 2021

Low dose of Moderna COVID-19 vaccine generates durable immune response

A new study from La Jolla Institute for Immunology (LJI) scientists helps answer the question: how long does immunity against COVID-19 last in vaccinated people?

14 Sep 2021

COVID-19 booster vaccine to be offered to millions of vulnerable people from next week

Millions of vulnerable people are to be offered a COVID-19 booster vaccine from next week as the government confirms it has accepted the final advice from the independent Joint Committee on Vaccination and Immunisation (JCVI).

14 Sep 2021

Novel combination therapy may prolong viral suppression in patients with HIV

A novel combination treatment may increase the ability of monoclonal antibodies to control viral infection in patients diagnosed with HIV, according to a Northwestern Medicine study published in Science Translational Medicine.

9 Sep 2021

Researchers use amphibian foam to deliver drugs for the first time

Amphibian foam has been used in drug delivery for the first time by researchers, which could help to combat the rise of antimicrobial resistance.

9 Sep 2021

Allergic reactions provide protection against yeast-triggered asthma, research shows

We think of asthma and other allergic diseases as unnecessary aberrant immune responses that do more harm than good. However, new evidence by an international team led by researchers at Baylor College of Medicine shows that some allergic reactions provide necessary protection against highly invasive and potentially lethal infectious agents, such as yeast.

9 Sep 2021

Restoring beneficial gut microbes to enhance the efficacy of cancer immunotherapy

The gut microbiome-;the collection of bacteria, viruses, fungi, and other microorganisms that reside in our gastrointestinal tracts-;can impact us in a variety of different ways, from our metabolism to our mood.

9 Sep 2021

Molecular underpinning of chronic bone infection in patients with mycobacterial disease revealed

About a quarter of the world's population is infected with tuberculosis bacteria, according to the World Health Organization, but only about 5 to 10% of those infected will develop symptoms. These pathogens are mycobacteria, which are everywhere, including in chlorine-treated tap water.

8 Sep 2021

Allergies News and Research

Latest Allergies News and Research

A daily pill to treat covid could be just months away, scientists say

COVID-19 transmission is higher with warm weather and increased visits to indoors public places, study finds

Researchers provide structural insights into HCV receptor binding and entry

Medical staff with a history of allergy suffered adverse reactions to BNT162b2 COVID-19 vaccine

COVID-19 vaccine-related allergies are rare, typically mild and treatable, finds study

Study uncovers five new genetic loci predisposing to atopic dermatitis

UW Medicine enrolls volunteers for COVID-19 booster vaccine trial

Discovery of biological response platform could provide opportunity to alleviate allergic inflammation

How Fauci and the NIH got ahead of the FDA and CDC in backing boosters

Phase I trial investigates using antiparasitic nitazoxanide for treatment of COVID-19

Low dose of Moderna COVID-19 vaccine generates durable immune response

COVID-19 booster vaccine to be offered to millions of vulnerable people from next week

Novel combination therapy may prolong viral suppression in patients with HIV

Researchers use amphibian foam to deliver drugs for the first time

Allergic reactions provide protection against yeast-triggered asthma, research shows

Restoring beneficial gut microbes to enhance the efficacy of cancer immunotherapy

Molecular underpinning of chronic bone infection in patients with mycobacterial disease revealed

COVID-19 infection does not appear to affect the lung function of young adults, finds study

Researchers find evidence that exercise during pregnancy benefits mothers and their offspring

Weill Cornell receives NIH support to advance TB research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in